Breast screening: the psychological sequelae of false-positive recall in women with and without a family history of breast cancer

Fiona Jane Gilbert, C M Cordiner, I R Affleck, D B Hood, Derek Mathieson, L G Walker

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

The psychological effects of false-positive mammography were evaluated in 124 women who had taken part in the U.K. National Health Service Breast Screening Programme. In addition, the effects of recall on women with and without a family history were compared. These women were asked to complete the Hospital Anxiety and Depression Scale (HADS) before being invited to attend for screening, at recall and 5 weeks and 4 months after recall. At screening and at recall, the women were asked to complete the Health Questionnaire (HQ) which measures stress-related behaviour changes in the previous week. In the week before screening, compared with women who did not have a family history of breast cancer, women with a family history had lower scores on HADS depression and reported fewer stress-related behaviour changes. At recall, regardless of family history, the women were more likely to have borderline or clinically significant anxiety than at baseline or screening. Nevertheless, for most women, recall-induced anxiety was relatively transient (less than 5 weeks). Compared with women without a family history, women with a family history were more anxious 4 months after recall, although their anxiety scores tended to be lower (P < 0.06) than at baseline. A strength of the present study is that the initial baseline measure was uncontaminated by the screening process. Women who did not complete questionnaires at one or more of the subsequent time points scored higher on HADS depression at baseline, indicating that the results are likely tot have underestimated the effects of recall. Screening appears to be less stressful for women with a family history than for those without a history. However, for both groups recall causes short term distress. Breast screening programmes should ensure that steps are taken to minimise the number of women who are recalled for unnecessary investigations. (C) 1998 Elsevier Science Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)2010-2014
Number of pages5
JournalEuropean Journal of Cancer
Volume34
Issue number13
DOIs
Publication statusPublished - Dec 1998

Keywords

  • breast screening
  • psychological distress
  • breast cancer
  • familial risk
  • ANXIETY
  • familial cancer

Cite this

Breast screening : the psychological sequelae of false-positive recall in women with and without a family history of breast cancer. / Gilbert, Fiona Jane; Cordiner, C M ; Affleck, I R; Hood, D B ; Mathieson, Derek; Walker, L G .

In: European Journal of Cancer, Vol. 34, No. 13, 12.1998, p. 2010-2014.

Research output: Contribution to journalArticle

Gilbert, Fiona Jane ; Cordiner, C M ; Affleck, I R ; Hood, D B ; Mathieson, Derek ; Walker, L G . / Breast screening : the psychological sequelae of false-positive recall in women with and without a family history of breast cancer. In: European Journal of Cancer. 1998 ; Vol. 34, No. 13. pp. 2010-2014.
@article{50315012f8f9492eb3c597fef82acd37,
title = "Breast screening: the psychological sequelae of false-positive recall in women with and without a family history of breast cancer",
abstract = "The psychological effects of false-positive mammography were evaluated in 124 women who had taken part in the U.K. National Health Service Breast Screening Programme. In addition, the effects of recall on women with and without a family history were compared. These women were asked to complete the Hospital Anxiety and Depression Scale (HADS) before being invited to attend for screening, at recall and 5 weeks and 4 months after recall. At screening and at recall, the women were asked to complete the Health Questionnaire (HQ) which measures stress-related behaviour changes in the previous week. In the week before screening, compared with women who did not have a family history of breast cancer, women with a family history had lower scores on HADS depression and reported fewer stress-related behaviour changes. At recall, regardless of family history, the women were more likely to have borderline or clinically significant anxiety than at baseline or screening. Nevertheless, for most women, recall-induced anxiety was relatively transient (less than 5 weeks). Compared with women without a family history, women with a family history were more anxious 4 months after recall, although their anxiety scores tended to be lower (P < 0.06) than at baseline. A strength of the present study is that the initial baseline measure was uncontaminated by the screening process. Women who did not complete questionnaires at one or more of the subsequent time points scored higher on HADS depression at baseline, indicating that the results are likely tot have underestimated the effects of recall. Screening appears to be less stressful for women with a family history than for those without a history. However, for both groups recall causes short term distress. Breast screening programmes should ensure that steps are taken to minimise the number of women who are recalled for unnecessary investigations. (C) 1998 Elsevier Science Ltd. All rights reserved.",
keywords = "breast screening, psychological distress, breast cancer, familial risk, ANXIETY, familial cancer",
author = "Gilbert, {Fiona Jane} and Cordiner, {C M} and Affleck, {I R} and Hood, {D B} and Derek Mathieson and Walker, {L G}",
year = "1998",
month = "12",
doi = "10.1016/S0959-8049(98)00294-9",
language = "English",
volume = "34",
pages = "2010--2014",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "ELSEVIER APPL SCI PUBL LTD",
number = "13",

}

TY - JOUR

T1 - Breast screening

T2 - the psychological sequelae of false-positive recall in women with and without a family history of breast cancer

AU - Gilbert, Fiona Jane

AU - Cordiner, C M

AU - Affleck, I R

AU - Hood, D B

AU - Mathieson, Derek

AU - Walker, L G

PY - 1998/12

Y1 - 1998/12

N2 - The psychological effects of false-positive mammography were evaluated in 124 women who had taken part in the U.K. National Health Service Breast Screening Programme. In addition, the effects of recall on women with and without a family history were compared. These women were asked to complete the Hospital Anxiety and Depression Scale (HADS) before being invited to attend for screening, at recall and 5 weeks and 4 months after recall. At screening and at recall, the women were asked to complete the Health Questionnaire (HQ) which measures stress-related behaviour changes in the previous week. In the week before screening, compared with women who did not have a family history of breast cancer, women with a family history had lower scores on HADS depression and reported fewer stress-related behaviour changes. At recall, regardless of family history, the women were more likely to have borderline or clinically significant anxiety than at baseline or screening. Nevertheless, for most women, recall-induced anxiety was relatively transient (less than 5 weeks). Compared with women without a family history, women with a family history were more anxious 4 months after recall, although their anxiety scores tended to be lower (P < 0.06) than at baseline. A strength of the present study is that the initial baseline measure was uncontaminated by the screening process. Women who did not complete questionnaires at one or more of the subsequent time points scored higher on HADS depression at baseline, indicating that the results are likely tot have underestimated the effects of recall. Screening appears to be less stressful for women with a family history than for those without a history. However, for both groups recall causes short term distress. Breast screening programmes should ensure that steps are taken to minimise the number of women who are recalled for unnecessary investigations. (C) 1998 Elsevier Science Ltd. All rights reserved.

AB - The psychological effects of false-positive mammography were evaluated in 124 women who had taken part in the U.K. National Health Service Breast Screening Programme. In addition, the effects of recall on women with and without a family history were compared. These women were asked to complete the Hospital Anxiety and Depression Scale (HADS) before being invited to attend for screening, at recall and 5 weeks and 4 months after recall. At screening and at recall, the women were asked to complete the Health Questionnaire (HQ) which measures stress-related behaviour changes in the previous week. In the week before screening, compared with women who did not have a family history of breast cancer, women with a family history had lower scores on HADS depression and reported fewer stress-related behaviour changes. At recall, regardless of family history, the women were more likely to have borderline or clinically significant anxiety than at baseline or screening. Nevertheless, for most women, recall-induced anxiety was relatively transient (less than 5 weeks). Compared with women without a family history, women with a family history were more anxious 4 months after recall, although their anxiety scores tended to be lower (P < 0.06) than at baseline. A strength of the present study is that the initial baseline measure was uncontaminated by the screening process. Women who did not complete questionnaires at one or more of the subsequent time points scored higher on HADS depression at baseline, indicating that the results are likely tot have underestimated the effects of recall. Screening appears to be less stressful for women with a family history than for those without a history. However, for both groups recall causes short term distress. Breast screening programmes should ensure that steps are taken to minimise the number of women who are recalled for unnecessary investigations. (C) 1998 Elsevier Science Ltd. All rights reserved.

KW - breast screening

KW - psychological distress

KW - breast cancer

KW - familial risk

KW - ANXIETY

KW - familial cancer

U2 - 10.1016/S0959-8049(98)00294-9

DO - 10.1016/S0959-8049(98)00294-9

M3 - Article

VL - 34

SP - 2010

EP - 2014

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 13

ER -